Xenon Pharmaceuticals
XENE
XENE
204 hedge funds and large institutions have $3.33B invested in Xenon Pharmaceuticals in 2023 Q4 according to their latest regulatory filings, with 46 funds opening new positions, 86 increasing their positions, 51 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
13% more funds holding
Funds holding: 180 → 204 (+24)
2.19% more ownership
Funds ownership: 95.63% → 97.83% (+2.2%)
4% less call options, than puts
Call options by funds: $39M | Put options by funds: $40.6M
Holders
204
Holding in Top 10
14
Calls
$39M
Puts
$40.6M
Top Buyers
| 1 | +$112M | |
| 2 | +$64.6M | |
| 3 | +$49.5M | |
| 4 |
FLAM
First Light Asset Management
Edina,
Minnesota
|
+$48.1M |
| 5 |
T. Rowe Price Investment Management
Baltimore,
Maryland
|
+$41M |
Top Sellers
| 1 | -$43.2M | |
| 2 | -$35.3M | |
| 3 | -$28.8M | |
| 4 |
SC
Samlyn Capital
New York
|
-$24.4M |
| 5 |
B
Braidwell
Stamford,
Connecticut
|
-$21M |